Leveget Indications/Uses

Film-coated tablet: Levetiracetam (Leveget) Tablet is indicated as: Monotherapy: In the treatment of partial onset seizures with or without secondary generalization in adults and adolescents from 16 years of age with newly diagnosed epilepsy.
Adjunctive Therapy: In the treatment of partial onset seizures with or without secondary generalization in adults, adolescents and children 6 years of age or above with epilepsy.
In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.
In the treatment of primary generalized tonic-clonic seizures in adults and adolescents from 6 years of age with Idiopathic Generalized Epilepsy.
Solution for injection: Partial Onset Seizures: Levetiracetam (Leveget) IV Injection is indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 1 month of age and older with epilepsy. Levetiracetam (Leveget) IV Injection is for intravenous use only as an alternative for patients when oral administration is temporarily not feasible.
Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy: Levetiracetam (Leveget) IV Injection is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years of age and older with juvenile myoclonic epilepsy. Levetiracetam (Leveget) IV Injection is for intravenous use only as an alternative for patients when oral administration is temporarily not feasible.
Primary Generalized Tonic-Clonic Seizures: Levetiracetam (Leveget) IV Injection is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy. Levetiracetam (Leveget) IV Injection is for intravenous use only as an alternative for patients when oral administration is temporarily not feasible.